Erwan Pencreach - Search Results

Year	Number of Results
2003	1
2005	1
2007	1
2009	1
2012	1
2013	3
2014	1
2015	1
2017	2
2018	2
2019	4
2020	2
2021	1
2022	4
2023	6
2024	0

1

Primary resistance to ALK inhibitors in KLC1/ALK-rearranged pleural metastatic lung adenocarcinoma: a case report.

Siblini L, Schott R, Trensz P, Pencreach E, Bender L. Siblini L, et al. Among authors: pencreach e. Transl Lung Cancer Res. 2023 Nov 30;12(11):2342-2346. doi: 10.21037/tlcr-23-482. Epub 2023 Nov 28. Transl Lung Cancer Res. 2023. PMID: 38090529 Free PMC article.

2

Patient-Derived Tumoroid for the Prediction of Radiotherapy and Chemotherapy Responses in Non-Small-Cell Lung Cancer.

Nounsi A, Seitlinger J, Ponté C, Demiselle J, Idoux-Gillet Y, Pencreach E, Beau-Faller M, Lindner V, Balloul JM, Quemeneur E, Burckel H, Noël G, Olland A, Fioretti F, Falcoz PE, Benkirane-Jessel N, Hua G. Nounsi A, et al. Among authors: pencreach e. Biomedicines. 2023 Jun 26;11(7):1824. doi: 10.3390/biomedicines11071824. Biomedicines. 2023. PMID: 37509464 Free PMC article.

3

Prognostic and Predictive Biomarkers in the Era of Immunotherapy for Lung Cancer.

Pabst L, Lopes S, Bertrand B, Creusot Q, Kotovskaya M, Pencreach E, Beau-Faller M, Mascaux C. Pabst L, et al. Among authors: pencreach e. Int J Mol Sci. 2023 Apr 20;24(8):7577. doi: 10.3390/ijms24087577. Int J Mol Sci. 2023. PMID: 37108738 Free PMC article. Review.

4

Acquired L718V/TP53 co-mutation and discordant molecular pattern between plasmatic and cerebrospinal fluid in a bone and meningeal metastatic L858R+ non-small cell lung cancer: a case report.

Schultz É, Pencreach E, Rimelen V, Palama A, Holder É, Gantzer J, Bender L. Schultz É, et al. Among authors: pencreach e. Ann Transl Med. 2023 Mar 15;11(5):223. doi: 10.21037/atm-22-3861. Epub 2023 Mar 13. Ann Transl Med. 2023. PMID: 37007549 Free PMC article.

5

p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances.

Geyer L, Wolf T, Chenard MP, Cebula H, Schott R, Noel G, Guerin E, Pencreach E, Reita D, Entz-Werlé N, Lhermitte B. Geyer L, et al. Among authors: pencreach e. Cancers (Basel). 2023 Feb 28;15(5):1512. doi: 10.3390/cancers15051512. Cancers (Basel). 2023. PMID: 36900302 Free PMC article.

6

All pineal tumors expressing germ cell tumor markers are not necessarily germ cell tumors: histopathological and molecular study of a midline primary intracranial sarcoma DICER1-mutant.

Wolf T, Coca AH, Weingertner N, Chenard MP, Meurgey A, Reita D, Pencreach E, Varlet P, Entz-Werlé N, Lhermitte B. Wolf T, et al. Among authors: pencreach e. Virchows Arch. 2023 Feb;482(2):431-435. doi: 10.1007/s00428-022-03440-2. Epub 2022 Oct 28. Virchows Arch. 2023. PMID: 36307659

7

The EXTREME Regimen Associating Cetuximab and Cisplatin Favors Head and Neck Cancer Cell Death and Immunogenicity with the Induction of an Anti-Cancer Immune Response.

De Azevedo J, Mourtada J, Bour C, Devignot V, Schultz P, Borel C, Pencreach E, Mellitzer G, Gaiddon C, Jung AC. De Azevedo J, et al. Among authors: pencreach e. Cells. 2022 Sep 14;11(18):2866. doi: 10.3390/cells11182866. Cells. 2022. PMID: 36139440 Free PMC article.

8

Engineering Novel 3D Models to Recreate High-Grade Osteosarcoma and its Immune and Extracellular Matrix Microenvironment.

Pierrevelcin M, Flacher V, Mueller CG, Vauchelles R, Guerin E, Lhermitte B, Pencreach E, Reisch A, Muller Q, Doumard L, Boufenghour W, Klymchenko AS, Foppolo S, Nazon C, Weingertner N, Martin S, Briandet C, Laithier V, Di Marco A, Bund L, Obrecht A, Villa P, Dontenwill M, Entz-Werlé N. Pierrevelcin M, et al. Among authors: pencreach e. Adv Healthc Mater. 2022 Oct;11(19):e2200195. doi: 10.1002/adhm.202200195. Epub 2022 Sep 4. Adv Healthc Mater. 2022. PMID: 36057996

9

Direct Targeting KRAS Mutation in Non-Small Cell Lung Cancer: Focus on Resistance.

Reita D, Pabst L, Pencreach E, Guérin E, Dano L, Rimelen V, Voegeli AC, Vallat L, Mascaux C, Beau-Faller M. Reita D, et al. Among authors: pencreach e. Cancers (Basel). 2022 Mar 4;14(5):1321. doi: 10.3390/cancers14051321. Cancers (Basel). 2022. PMID: 35267628 Free PMC article. Review.

10

Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring.

Reita D, Pabst L, Pencreach E, Guérin E, Dano L, Rimelen V, Voegeli AC, Vallat L, Mascaux C, Beau-Faller M. Reita D, et al. Among authors: pencreach e. Cancers (Basel). 2021 Sep 30;13(19):4926. doi: 10.3390/cancers13194926. Cancers (Basel). 2021. PMID: 34638411 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year